A citation-based method for searching scientific literature

Abdi T Gudina, Glenn Copeland, Amr S Soliman, Kelly A Hirko. Breast Cancer Res Treat 2019
Times Cited: 5







List of co-cited articles
9 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.
S Dawood, S D Merajver, P Viens, P B Vermeulen, S M Swain, T A Buchholz, L Y Dirix, P H Levine, A Lucci, S Krishnamurthy,[...]. Ann Oncol 2011
306
60

Inflammatory breast cancer: the disease, the biology, the treatment.
Fredika M Robertson, Melissa Bondy, Wei Yang, Hideko Yamauchi, Shannon Wiggins, Samira Kamrudin, Savitri Krishnamurthy, Huong Le-Petross, Luc Bidaut, Audrey N Player,[...]. CA Cancer J Clin 2010
202
60

Underuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database.
Natasha M Rueth, Heather Y Lin, Isabelle Bedrosian, Simona F Shaitelman, Naoto T Ueno, Yu Shen, Gildy Babiera. J Clin Oncol 2014
79
40

Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
Tamer M Fouad, Takahiro Kogawa, Diane D Liu, Yu Shen, Hiroko Masuda, Randa El-Zein, Wendy A Woodward, Mariana Chavez-MacGregor, Ricardo H Alvarez, Banu Arun,[...]. Breast Cancer Res Treat 2015
52
40


Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma.
R Y Fleming, L Asmar, A U Buzdar, M D McNeese, F C Ames, M I Ross, S E Singletary. Ann Surg Oncol 1997
69
40

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.
Kenneth W Hance, William F Anderson, Susan S Devesa, Heather A Young, Paul H Levine. J Natl Cancer Inst 2005
412
40

Epidemiology of inflammatory breast cancer (IBC).
William F Anderson, Catherine Schairer, Bingshu E Chen, Kenneth W Hance, Paul H Levine. Breast Dis 2005
135
40

Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center.
N T Ueno, A U Buzdar, S E Singletary, F C Ames, M D McNeese, F A Holmes, R L Theriault, E A Strom, B J Wasaff, L Asmar,[...]. Cancer Chemother Pharmacol 1997
167
40


Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database.
Jieqiong Liu, Kai Chen, Wen Jiang, Kai Mao, Shunrong Li, Min Ji Kim, Qiang Liu, Lisa K Jacobs. J Cancer Res Clin Oncol 2017
24
20

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
20

Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer.
Jingyu Zhou, Yi Yan, Lei Guo, Huiying Ou, Jian Hai, Chaojie Zhang, Zhaoyun Wu, Lili Tang. Saudi Med J 2014
13
20

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
Gunter von Minckwitz, Michael Untch, Jens-Uwe Blohmer, Serban D Costa, Holger Eidtmann, Peter A Fasching, Bernd Gerber, Wolfgang Eiermann, Jörn Hilfrich, Jens Huober,[...]. J Clin Oncol 2012
20

Inflammatory breast cancer: an overview.
D J P van Uden, H W M van Laarhoven, A H Westenberg, J H W de Wilt, C F J M Blanken-Peeters. Crit Rev Oncol Hematol 2015
74
20


Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades.
Reina Haque, Syed A Ahmed, Galina Inzhakova, Jiaxiao Shi, Chantal Avila, Jonathan Polikoff, Leslie Bernstein, Shelley M Enger, Michael F Press. Cancer Epidemiol Biomarkers Prev 2012
133
20

Inflammatory breast cancer in the Netherlands; improved survival over the last decades.
D J P van Uden, R Bretveld, S Siesling, J H W de Wilt, C F J M Blanken-Peeters. Breast Cancer Res Treat 2017
20
20

Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy.
Waqar Haque, Vivek Verma, Sandra Hatch, V Suzanne Klimberg, E Brian Butler, Bin S Teh. Breast Cancer Res Treat 2018
103
20

HER2-targeted therapy in breast cancer: a systematic review of neoadjuvant trials.
Susan Dent, Basak Oyan, Arnd Honig, Max Mano, Sacha Howell. Cancer Treat Rev 2013
64
20

Risk factors for inflammatory breast cancer and other invasive breast cancers.
Catherine Schairer, Yan Li, Peter Frawley, Barry I Graubard, Robert D Wellman, Diana S M Buist, Karla Kerlikowske, Tracy L Onega, William F Anderson, Diana L Miglioretti. J Natl Cancer Inst 2013
47
20

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients.
M J Engstrøm, S Opdahl, A I Hagen, P R Romundstad, L A Akslen, O A Haugen, L J Vatten, A M Bofin. Breast Cancer Res Treat 2013
139
20

Prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients: a prospective observational study.
Xi Jin, Yi-Zhou Jiang, Sheng Chen, Ke-Da Yu, Zhi-Ming Shao, Gen-Hong Di. Oncotarget 2015
32
20


Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes.
H Masuda, T M Brewer, D D Liu, T Iwamoto, Y Shen, L Hsu, J S Willey, A M Gonzalez-Angulo, M Chavez-MacGregor, T M Fouad,[...]. Ann Oncol 2014
81
20

Completeness of cancer registration in Limburg, The Netherlands.
L J Schouten, P Höppener, P A van den Brandt, J A Knottnerus, J J Jager. Int J Epidemiol 1993
301
20

Identifying factors that impact survival among women with inflammatory breast cancer.
S Dawood, N T Ueno, V Valero, W A Woodward, T A Buchholz, G N Hortobagyi, A M Gonzalez-Angulo, M Cristofanilli. Ann Oncol 2012
36
20

Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatment.
Laura Orlando, Giuseppe Viale, Emilio Bria, Eufemia Stefania Lutrino, Isabella Sperduti, Luisa Carbognin, Paola Schiavone, Annamaria Quaranta, Palma Fedele, Chiara Caliolo,[...]. Breast 2016
28
20

Incidence of inflammatory breast cancer in women, 1992-2009, United States.
Bryan Goldner, Carolyn E Behrendt, Hans F Schoellhammer, Byrne Lee, Steven L Chen. Ann Surg Oncol 2014
20
20

Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
Tina J Hieken, Brittany L Murphy, Judy C Boughey, Amy C Degnim, Katrina N Glazebrook, Tanya L Hoskin. Clin Breast Cancer 2018
13
20

Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype.
Dang M Nguyen, Kathy Sam, Anna Tsimelzon, Xiaoxian Li, Helen Wong, Syed Mohsin, Gary M Clark, Susan G Hilsenbeck, Richard M Elledge, D Craig Allred,[...]. Clin Cancer Res 2006
62
20

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Cornelia Liedtke, Chafika Mazouni, Kenneth R Hess, Fabrice André, Attila Tordai, Jaime A Mejia, W Fraser Symmans, Ana M Gonzalez-Angulo, Bryan Hennessy, Marjorie Green,[...]. J Clin Oncol 2008
20

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
Manfred Kaufmann, Gabriel N Hortobagyi, Aron Goldhirsch, Suzy Scholl, Andreas Makris, Pinuccia Valagussa, Jens-Uwe Blohmer, Wolfgang Eiermann, Raimund Jackesz, Walter Jonat,[...]. J Clin Oncol 2006
445
20


Luminal B breast cancer: patterns of recurrence and clinical outcome.
Zhi-Hua Li, Ping-Hua Hu, Jian-Hong Tu, Ni-Si Yu. Oncotarget 2016
44
20

Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers.
Audrey Monneur, Anthony Goncalves, Marine Gilabert, Pascal Finetti, Carole Tarpin, Christophe Zemmour, Jean-Marc Extra, Agnès Tallet, Eric Lambaudie, Jocelyne Jacquemier,[...]. Oncotarget 2017
9
20

Generational Differences in Mentoring Relationships-Reply.
Jennifer F Waljee, Vineet Chopra, Sanjay Saint. JAMA 2018
2
50


Teaching epidemiology concepts experientially: a "real" foodborne outbreak in the classroom.
Kristen Pogreba-Brown, Kacey Ernst, Robin Harris. Public Health Rep 2012
4
25

Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008).
Kelly A Hirko, Amr S Soliman, Mousumi Banerjee, Julie Ruterbusch, Joe B Harford, Robert M Chamberlain, John J Graff, Sofia D Merajver, Kendra Schwartz. Springerplus 2013
10
20


Epidemiologic profile of pediatric brain tumors in Morocco.
Mehdi Karkouri, Sadia Zafad, Mohammed Khattab, Noureddine Benjaafar, Hanan El Kacemi, Sana Sefiani, Fouad Kettani, Subhojit Dey, Amr S Soliman. Childs Nerv Syst 2010
37
20

Characteristics of success in mentoring and research productivity - a case-control study of academic centers.
Joshua G Cohen, Alexander E Sherman, Tuyen K Kiet, Daniel S Kapp, Kathryn Osann, Lee-may Chen, Patricia S O'Sullivan, John K Chan. Gynecol Oncol 2012
43
20

Incidence analyses of bladder cancer in the Nile delta region of Egypt.
Stacey A Fedewa, Amr S Soliman, Kadry Ismail, Ahmed Hablas, Ibrahim A Seifeldin, Mohamed Ramadan, Hoda G Omar, Jerome Nriagu, Mark L Wilson. Cancer Epidemiol 2009
48
20

A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.
Kelly A Hirko, Amr S Soliman, Mousumi Banerjee, Julie Ruterbusch, Joe B Harford, Sofia D Merajver, Kendra Schwartz. Breast J 2014
10
20

Disaggregating Hispanic American Cancer Mortality Burden by Detailed Ethnicity.
Steven M Zamora, Paulo S Pinheiro, Scarlett Lin Gomez, Katherine G Hastings, Latha P Palaniappan, Jiaqi Hu, Caroline A Thompson. Cancer Epidemiol Biomarkers Prev 2019
16
20


Trends in Breast Cancer Incidence Rates by Age and Stage at Diagnosis in Gharbiah, Egypt, over 10 Years (1999-2008).
Kelly A Hirko, Amr S Soliman, Ahmed Hablas, Ibrahim A Seifeldin, Mohamed Ramadan, Mousumi Banerjee, Joe B Harford, Robert M Chamberlain, Sofia D Merajver. J Cancer Epidemiol 2013
29
20

The National Cancer Institute R25 Cancer Education Grants Program: A Workshop Report.
Jeannette F Korczak, Davyd W Chung, Erica Rosemond, Daniel D Von Hoff, Richard L Haspel, John W Waterbor, Shine Chang, Amelie G Ramirez, Susan Perkins, Jonathan Wiest,[...]. J Cancer Educ 2017
5
20

The benefits of experiential learning in global public health.
C X J Hu, A Abraham, A K Mitra, S M Griffiths. Public Health 2016
6
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.